Admission Date:  [**2114-11-18**]              Discharge Date:   [**2114-12-6**]  Date of Birth:  [**2073-4-19**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1505**] Chief Complaint: weight gain, DOE  Major Surgical or Invasive Procedure: Redo sternotomy/MVR923mm St. [**Male First Name (un) 923**] mechanical)/TV repair(28mm annuloplasty band) [**2114-11-26**]   History of Present Illness: Patient is a 41yo woman with h/o DM type [**First Name8 (NamePattern2) 30749**] [**First Name5 (NamePattern1) 923**] [**Last Name (NamePattern1) 1291**] in [**2112**] (congenital bicuspid valve) who presents for right heart catheterization in anticipation of MVR.
[**Name2 (NI) **] was diuresed with lasix with improvement in her fluid status and dyspnea.
On review of systems, she denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools.
Past Medical History: Type 1 DM--A1C 7.5% in [**2114-9-22**]; c/b peripheral neuropathy and retinopathy; on insulin pump [**Year (4 digits) 1291**] [**2112-3-22**]: St. [**Male First Name (un) 923**] 19 mm valve.
Also with h/o percocet abuse, sober x5 years.
Skin: + Hypopigmented macules on chest, arms, legs, and trunk, most prominent on chest and arms.
[**Hospital1 18**] ECHOCARDIOGRAPHY REPORT  [**Known lastname **], [**Known firstname **] M       [**Hospital1 18**] [**Numeric Identifier 30750**] (Complete) Done [**2114-11-26**] at 1:53:55 PM      FINAL Referring Physician     [**Name9 (PRE) **] Information [**Name9 (PRE) **], [**First Name3 (LF) **] R. Division of Cardiothoracic [**Doctor First Name **] [**Hospital Unit Name 4081**] [**Location (un) 86**], [**Numeric Identifier 718**]  Status: Inpatient DOB: [**2073-4-19**] Age (years): 41 F  Hgt (in): BP (mm Hg): /  Wgt (lb): HR (bpm):  BSA (m2): Indication: Intraoperative TEE for MVR/TVR ICD-9 Codes: 440.0, 424.1, 394.2, 424.2 Test Information Date/Time: [**2114-11-26**] at 13:53    Interpret MD: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 4901**], MD Test Type: TEE (Complete) Son[**Name (NI) 930**]: [**Name Initial (MD) **] [**Name8 (MD) 4901**], MD Doppler: Full Doppler and color Doppler Test Location: Anesthesia West OR cardiac Contrast: None Tech Quality: Suboptimal Tape #: 2007AW4-: Machine: 4 Echocardiographic Measurements Results  Measurements  Normal Range Left Ventricle - Septal Wall Thickness:  0.8 cm  0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness:  0.9 cm  0.6 - 1.1 cm  Left Ventricle - Diastolic Dimension:  4.6 cm  <= 5.6 cm Left Ventricle - Ejection Fraction:  40% to 45%  >= 55% Aorta - Ascending:  2.4 cm  <= 3.4 cm Aorta - Arch:  2.0 cm  <= 3.0 cm Aorta - Descending Thoracic:  1.5 cm  <= 2.5 cm Aortic Valve - Peak Gradient:  *20 mm Hg  < 20 mm Hg Aortic Valve - Mean Gradient:  13 mm Hg Aortic Valve - Valve Area:  *1.1 cm2  >= 3.0 cm2 Mitral Valve - Peak Velocity:  2.3 m/sec Mitral Valve - Mean Gradient:  9 mm Hg Mitral Valve - MVA (P [**1-23**] T):  1.1 cm2  Findings LEFT ATRIUM: Dilated LA.
RIGHT ATRIUM/INTERATRIAL SEPTUM: A catheter or pacing wire is seen in the RA and extending into the RV.
AORTIC VALVE: Bileaflet aortic valve prosthesis ([**Last Name (Prefixes) 1291**]).
The patient was under general anesthesia throughout the procedure.
A bileaflet aortic valve prosthesis is present.
POST CPB The patient is receiving milrinone and epinephrine by infusion.
A bileaflet prosthesis is located in the mitral position.
She was started on a heparin gtt.
She was seen by nephrology for hyponatremia, and was fluid restricted and her doses of trileptal and celexa were reduced.
She was taken to the operating room on [**2114-11-26**] where she underwent a redo-sternotomy, MVR(mechanical) and TV repair.
She was weaned from her vasoactive drips by POD #2.
She was started on heparin for her mechanical valves.
Her rhythm recovered, she was started on coumadin and her epicardial pacing wires were dc'd.
Her INR was scheduled to be checked by visiting nursing on the day after her discharge.
Medications on Admission: Insulin pump Valsartan 120 mg PO daily Buspirone 20 mg PO tid Trazodone 300 mg qhs Atenolol 25 mg PO daily Celexa 80 mg PO daily Wellbutrin SR 200 mg PO bid Atorvastatin 80 mg PO daily Oxcarbazepine 900 mg PO qhs Coumadin 7-8mg QHS Furosemide 20 mg PO daily --not taking her iron or ASA  Discharge Medications: 1.
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for pain.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Citalopram 20 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily).
Valsartan 40 mg Tablet Sig: Three (3) Tablet PO DAILY (Daily).
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Bupropion 100 mg Tablet Sustained Release Sig: Two (2) Tablet Sustained Release PO BID (2 times a day).
Oxcarbazepine 300 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Buspirone 10 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day).
Warfarin 2 mg Tablet Sig: One (1) Tablet PO ONCE (Once) for 1 doses: check INR [**12-7**] with results to [**Hospital1 18**] coumadin clinic/[**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 9449**].
Lasix 20 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*0*   Discharge Disposition: Home With Service  Facility: [**Company **]  Discharge Diagnosis: MR, TR now s/p MVR/TVRepair HTN, ^chol, DM I, neuropathy, anxiety, eye sx, shoulder sx, c sec, s/p [**Company 1291**](19mm St. [**First Name4 (NamePattern1) 923**] [**Last Name (NamePattern1) **]) [**3-26**] c/b sternal dehiscence, retinopathy, anemia, depression, restless leg syndrome   Discharge Condition: good.
Shower, no baths, no lotions, creams or powders to incisions.
Followup Instructions: Dr. [**Last Name (STitle) **] 4 weeks Dr. [**Last Name (STitle) 30747**] 2 weeks Coumadin follow up with [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 9449**] [**2114**] Already Scheduled appointments: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 1523**], MD Phone:[**Telephone/Fax (1) 4022**] Date/Time:[**2114-12-31**] 1:40    Completed by:[**2114-12-6**
